Wegovy self-pay price
Brand-name semaglutide, cash price, via NovoCare Pharmacy — pens and the oral form, with the conditions that move the number.
As of August 31, 2026:
Wegovy self-pay through NovoCare Pharmacy is $349 per month for pens, with qualifying new patients paying $199 for initial fills (verified August 25, 2026, grade B); a modeled year is about $4,038. Oral Wegovy runs $149 per month at the lower doses and $299 at 9 and 25 mg, modeling to about $3,138 per year. The cheapest first-party-verified compounded semaglutide year is $1,056 (Sunlight, grade B) — with the same caveat in both directions: Wegovy is FDA-approved, compounded semaglutide is not.
| Provider | Plan | Advertised /mo | All-in /mo, maintenance dose | 12-month all-in | Dose pricing | Membership | Included | Grade | Verified | Change | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NovoCare Pharmacy brandbrand-name pen | month-to-month | $349 | $349 | $4,038 | rises with dose | none | care: paid; shipping included | B | — | novocare.com | |
| NovoCare Pharmacy brandbrand-name oral | month-to-month | $149 | $299 | $3,138 | rises with dose | none | care: paid; shipping included | B | — | novocare.com |
Grades: A = price and terms verified on the provider’s page; B = price verified, some terms unpublished; C = introductory price only; D = third-party report, not verified by us; U = no public price. Grade D rows are shown for completeness and are never counted in verified statistics. Full definitions.
Ozempic
Ozempic is the same molecule approved for type 2 diabetes; the dataset contains no verified cash-pay Ozempic program, so none is shown. Novo’s self-pay weight-loss route is Wegovy via NovoCare.
Wegovy versus compounded semaglutide on price
Verified compounded semaglutide starts at $88 per month against $349 for Wegovy pens. Wegovy is FDA-approved; compounded semaglutide is not. Full comparison: compounded vs Wegovy cost.
Questions this page answers
How much is Wegovy without insurance?
Wegovy self-pay through NovoCare Pharmacy is $349 per month for pens, with qualifying new patients paying $199 for initial fills (verified August 25, 2026, grade B); a modeled year is about $4,038. Oral Wegovy runs $149 per month at the lower doses and $299 at 9 and 25 mg, modeling to about $3,138 per year. The cheapest first-party-verified compounded semaglutide year is $1,056 (Sunlight, grade B) — with the same caveat in both directions: Wegovy is FDA-approved, compounded semaglutide is not.